Acquisition momentum InVita has been actively expanding through multiple acquisitions in 2026, including MAK-SYSTEM and IT Synergistics, signaling a growth trajectory and potential need for integrated solutions, migration services, and change management to unify legacy systems with InVita platforms.

End-to-end blood management Recent expansions into end-to-end blood management and advanced therapy capabilities open opportunities to upsell comprehensive HemaConnect services, integration with blood centers, and workflow enhancements across hospitals, organ recovery agencies, and donation organizations.

Regulated industry focus Target markets include Hospitals and Health Systems, Blood & Plasma Centers, Donation-Transplant networks, and Forensic Laboratories, indicating high demand for compliant, configurable software and potential cross-sell into new regulated segments with strict data integrity needs.

Global deployment potential MAK-SYSTEM acquisition broadens international reach; combined with iReferral and cloud-based tech stack, there’s an opportunity to monetize multi-region deployments, partner ecosystems, and scalable solutions for global health operations.

Strategic partnerships Active collaborations with Gulf Coast Blood, MORA, and participation in partner conferences suggest a fertile landscape for co-sell initiatives, referral programs, and joint go-to-market efforts to accelerate adoption of donation-transplant and advanced therapy modules.